Patent · US Active

Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them

US7550465B2 · kind B2 · utility

4Cited by

0References

11Claims

0Family size

Assignee

elbion GmbH · DE

Inventors

Norbert Höfgen · Radeberg, DE
Hans Stange · Riesa, DE
Barbara Langen · Radebeul, DE
Ute Egerland · Radebeul, DE
Rudolf Schindler · Dresden, DE
Thomas Pfeifer · Eppstein, DE
Chris Rundfeldt · Coswig, DE

Key dates

Filing date	May 24, 2007
Grant date	Jun 23, 2009
Priority date	—
Expiry date	Jun 22, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating diseases of mammals including a human which can be influenced by using the compounds according to the invention to inhibit phosphodiesterase 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.